Strategies for Screening and Managing Inflammatory Bowel Disease During Pregnancy
Abstract: Pregnancy is a critical phase of life for women; there are several hormonal changes during this period. Pregnant women, throughout their gestation, may be greatly impacted by disease condi-tions such as hypertension and diabetes mellitus. Inflammatory Bowel Disease (IBD) is a chronic condition involving inflammation of the gastrointestinal (GI) tract. Comprehending the connection between IBD and pregnancy is essential due to its effects on the pregestational, gestational, and post-partum phases. Pregnancy-related inflammatory bowel disease activity must be tracked using several techniques. The usefulness and reliability of small intestine ultrasound (IUS) as a trustworthy and noninvasive diagnostic tool are reviewed in this article. The increasing popularity of IUS requires skilled personnel for its effective use due to its technique-sensitive nature. In addition, this review provides an overview of the most recent data about the efficacy and safety of IBD treatments for expectant mothers to provide medical professionals with up-to-date clinical recommendations.
Authors
- Sharad Chand (ORCID: https://orcid.org/0000-0002-5777-0589)
- Rohit Singh (ORCID: https://orcid.org/0000-0002-4235-8436)
- Savita D. Patil
- Shiv Kumar Yadav
- Urmila Dattatray Nikam
Institutions
- MIT World Peace University (IN)
- Shri Vile Parle Kelavani Mandal (IN)
Publication Details
- Journal
- Current Drug Therapy
- Published
- 2025-10-17
- DOI
- https://doi.org/10.2174/0115748855394477250924234245
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00